3901 - 3910 of 8088 Results
Title
Year
-
OPENTitle: A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 81Issue #:Start Page: 144End Page: 150Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.029Best OA location URL: http://www.prd-journal.com/article/S1353802020308221/pdfCitation Count: 16
-
OPENTitle: Epigenome-wide association study of Alzheimer’s disease replicates 22 differentially methylated positions and 30 differentially methylated regionsJournal Name: Clinical EpigeneticsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13148-020-00944-zBest OA location URL: https://clinicalepigeneticsjournal.biomedcentral.com/track/pdf/10.1186/s13148-020-00944-zCitation Count: 62
-
OPENTitle: Lower Urinary Tract and Gastrointestinal Dysfunction Are Common in Early Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2020Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2020/1694547Best OA location URL: https://downloads.hindawi.com/journals/pd/2020/1694547.pdfCitation Count: 12
-
OPENTitle: Altered Functional Network Associated With Cognitive Performance in Early Parkinson Disease Measured by Eigenvector Centrality MappingJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2020.554660Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2020.554660/pdfCitation Count: 7
-
RESTRICTEDTitle: Inflammatory bowel disease and Parkinson’s disease: common pathophysiological linksJournal Name: GutPublisher: BMJVol:Issue #:Start Page: gutjnlEnd Page: 322429Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/gutjnl-2020-322429Best OA location URL: https://lirias.kuleuven.be/bitstream/123456789/663875/2/gutjnl-2020-322429_main_18_Aug_clean.pdfCitation Count: 93
-
RESTRICTEDTitle: Precision medicine in Parkinson’s disease patients with LRRK2 and GBA risk variants – Let’s get even more personalJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-020-00218-xBest OA location URL: https://translationalneurodegeneration.biomedcentral.com/track/pdf/10.1186/s40035-020-00218-xCitation Count: 29
-
OPENTitle: Classification of PPMI MRI scans with voxel-based morphometry and machine learning to assist in the diagnosis of Parkinson’s diseaseJournal Name: Computer Methods and Programs in BiomedicinePublisher: Elsevier BVVol: 198Issue #:Start Page: 105793End Page: 105793Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cmpb.2020.105793Best OA location URL: https://doi.org/10.1016/j.cmpb.2020.105793Citation Count: 87
- Gait Progression Over 6 Years in Parkinson’s Disease: Effects of Age, Medication, and Pathology2020OPENTitle: Gait Progression Over 6 Years in Parkinson’s Disease: Effects of Age, Medication, and PathologyJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page: